North American drug delivery development experts added to help guide Lexaria’s strategic plans KELOWNA, BC – Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery… Read More
The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an autologous stem cell transplant, followed by 24 months fixed-duration ibrutinib… Read More
It is with heartfelt congratulations that we share that Dr. Marco Marra has been appointed an Officer of the Order of Canada (O.C.). This honour, bestowed upon over 7,600 Canadians… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company“), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high… Read More
Sponsored by Ryan Dalrymple, mechanical engineer, an HDR Foundation grant to Partnership for Kids will help expand an immersive and engaging science, technology, engineering and math curriculum for middle and… Read More
